Community-onset Staphylococcus aureus infections presenting to general practices in South-eastern Australia

Epidemiology and Infection

Volumn 142, Issue 3, 2014, Pages 501-511

  Bennett, C M ^a,b   Coombs, G W ^c,d   Wood, G M ^e,f   Howden, B P ^a,e   Johnson, L E A ^a   White, D ^a   Johnson, P D R ^a,e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b DEAKIN UNIVERSITY   (Australia)

^c ROYAL PERTH HOSPITAL   (Australia)

^d CURTIN UNIVERSITY   (Australia)

^e AUSTIN HEALTH   (Australia)

^f Dorevitch Pathology   (Australia)

Author keywords

Epidemiology; Methicillin resistant S. aureus (MRSA); Public health emerging infections; Staphylococcal infections; Staphylococcus aureus

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; FUSIDIC ACID; GENTAMICIN; PANTON VALENTINE LEUKOCIDIN; PSEUDOMONIC ACID; RIFAMPICIN; TETRACYCLINE; TRIMETHOPRIM; FLUCLOXACILLIN; ANTIINFECTIVE AGENT;

ABSCESS; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIUM ISOLATE; COHORT ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FURUNCULOSIS; GENERAL PRACTICE; GENETIC ASSOCIATION; HEAD AND NECK INFECTION; HETEROZYGOTE; HUMAN; INFECTION SITE; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL PARAMETERS; MULTIDRUG RESISTANCE; MULTILOCUS SEQUENCE TYPING; NON MULTIRESISTANT METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PATHOGENESIS; PVL GENE; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS INFECTION; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIAL DIVERSITY; NON MULTIRESISTANT METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; STAPHYLOCOCCUS AUREUS; COMMUNITY ACQUIRED INFECTION; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; POLYMERASE CHAIN REACTION; PREVALENCE; SEVERITY OF ILLNESS INDEX; VICTORIA; VIRULENCE;

ADULT; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, BACTERIAL; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREVALENCE; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VICTORIA; VIRULENCE;

EID: 84896483150     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268813001581     Document Type: Article

References (38)

1. Munckhof WJ, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. International Journal of Infectious Diseases 2003; 7: 259-264.
2. Nimmo GR, et al. Methicillin-resistant Staphylococcus aureus in the Australian community: an evolving epidemic. Medical Journal of Australia 2006; 184: 384-388.
3. Miller LD, Kaplan SL. Staphylococcus aureus: a community pathogen. Infectious Disease Clinics of North America 2009; 23: 35-52.
4. Landrum ML, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. Journal of the American Medical Association. 2012; 308: 50-59.
5. Collignon P, et al. Staphylococcus aureus bacteremia, Australia. Emerging Infectious Diseases 2005; 11: 554-561.
6. Turnidge JD, et al. Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand. Medical Journal of Australia 2009; 191: 368- 373.
7. Peleg AY, Munckhof WJ. Fatal necrotising pneumonia due to community-acquired methicillin-resistant Staphylococcus aureus (MRSA). Medical Journal of Australia 2004; 181: 228-229.
8. Tong SY, et al. Clinical correlates of Panton-Valentine leukocidin (PVL), PVL isoforms, and clonal complex in the Staphylococcus aureus population of Northern Australia. Journal of Infectious Diseases 2010; 202: 760-769.
9. Lina G, et al. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clinical Infectious Diseases 1999; 29: 1128-1132.
10. Vandenesch F, et al. Community-acquired methicillinresistant Staphylococcus aureus carrying Panton- Valentine leukocidin genes: worldwide emergence. Emerging Infectious Diseases 2003; 9: 978-984.
11. Nimmo GR, Coombs GW. Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia. International Journal of Antimicrobial Agents 2008; 31: 401-410.
12. Lo WT, et al. Panton-Valentine leukocidin is associated with exacerbated skin manifestations and inflammatory response in children with community-associated staphylococcal scarlet fever. Clinical Infectious Diseases 2009; 49: 69-75.
13. Vandenesch F, et al. The Panton-Valentine leukocidin is a virulence factor in a murine model of necrotizing pneumonia. Journal of Infectious Diseases 2010; 201: 967-969.
14. Vandenesch F, et al. The end of the controversy: Panton Valentine is the culprit. Medical Science (Paris) 2009; 25: 984-986.
15. Villaruz AE, et al. A point mutation in the agr locus rather than expression of the Panton-Valentine leukocidin caused previously reported phenotypes in Staphylococcus aureus pneumonia and gene regulation. Journal of Infectious Diseases 2009; 200: 724-734.
16. Voyich JM, et al. Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? Journal of Infectious Diseases 2006; 194: 1761-1770.
17. Wehrhahn MC, et al. Illness severity in communityonset invasive Staphylococcus aureus infection and the presence of virulence genes. Journal of Infectious Diseases 2012; 205: 1840-1848.
18. Bell SM. The CDS disc method of antibiotic sensitivity testing (calibrated dichotomous sensitivity test). Pathology 1975; 7 (Suppl. 4): 1-48.
19. O'Brien FG, Udo EE, Grubb WB. Contour-clamped homogeneous electric field electrophoresis of Staphylococcus aureus. Nature Protocols 2006; 1: 3028-3033.
20. Fey PD, et al. Comparative molecular analysis of community- or hospital-acquired methicillin-resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 2003; 47: 196-203.
21. Nimmo GR, et al. Antimicrobial susceptibility of Staphylococcus aureus isolated from hospital inpatients, 2009: report from the Australian Group on Antimicrobial Resistance. Communicable Disease Intelligence Quarterly Report 2011; 35: 237-243.
22. Enright MC, et al. Multilocus sequence typing for characterization of methicillin-resistant and methicillinsusceptible clones of Staphylococcus aureus. Journal of Clinical Microbiology 2000; 38: 1008-1015.
23. Coombs G, et al. Differentiation of clonal complex 59 community-associated methicillin-resistant Staphylococcus aureus in Western Australia. Antimicrobial Agents and Chemotherapy 2010; 54: 1914-1921.
24. Blaine KP, et al. Progression to bacteremia in critical care patients colonized with methicillin-resistant Staphylococcus aureus expressing Panton-Valentine leukocidin. Diagnostic Microbiology and Infectious Disease 2010; 68: 28-33.
25. Chen SY, et al. Impact of traditional hospital strain of methicillin-resistant Staphylococcus aureus (MRSA) and community strain of MRSA on mortality in patients with community-onset S. aureus bacteremia. Medicine (Baltimore) 2010; 89: 285-294.
26. Ellington MJ, et al. Is Panton-Valentine leucocidin associated with the pathogenesis of Staphylococcus aureus bacteraemia in the UK? Journal Antimicrobial Chemotherapy 2007; 60: 402-405.
27. Wang JL, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clinical Infectious Diseases 2008; 46: 799-806.
28. Daskalaki M, et al. Panton-Valentine leukocidin-positive Staphylococcus aureus skin and soft tissue infections among children in an emergency department in Madrid, Spain. Clinical Microbiology and Infection 2010; 16: 74-77.
29. Muttaiyah S, et al. Incidence, risk factors, and outcomes of Panton-Valentine leukocidin-positive methicillinsusceptible Staphylococcus aureus infections in Auckland, New Zealand. Journal Clinical Microbiology 2010; 48: 3470-3474.
30. Berglund C, et al. The genes for Panton Valentine leukocidin (PVL) are conserved in diverse lines of methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Microbes and Infection 2008; 10: 878-884.
31. Gillet Y, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet 2002; 359: 753-759.
32. Gillet Y, et al. Association of necrotizing pneumonia with Panton-Valentine leukocidin-producing Staphylococcus aureus, regardless of methicillin resistance. Clinical Infectious Diseases 2008; 47: 985-986.
33. Cohen PR. Cutaneous community-acquired methicillinresistant Staphylococcus aureus infection in participants of athletic activities. Southern Medical Journal 2005; 98: 596-602.
34. del Giudice P, et al. Primary skin abscesses are mainly caused by Panton-Valentine leukocidin-positive Staphylococcus aureus strains. Dermatology 2009; 219: 299- 302.
35. Jahamy H, et al. Staphylococcus aureus skin/soft-tissue infections: the impact of SCCmec type and Panton- Valentine leukocidin. Scandinavian Journal of Infectious Diseases 2008; 40: 601-606.
36. Yamasaki O, et al. The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deep-seated follicular infection. Clinical Infectious Diseases 2005; 40: 381-385.
37. Munckhof WJ, et al. Nasal carriage of Staphylococcus aureus, including community-associated methicillinresistant strains, in Queensland adults. Clinical Microbiology and Infection 2009; 15: 149-155.
38. Hermos CR, Yoong P, Pier GB. High levels of antibody to Panton-Valentine leukocidin are not associated with resistance to Staphylococcus aureus-associated skin and soft-tissue infection. Clinical Infectious Diseases 2010; 51: 1138-1146.